ArticleBMC medicine2026

Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients.

Alexander Scheiter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.